| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quantitative Trait Loci | 31 | 2023 | 576 | 4.980 |
Why?
|
| Genetics, Population | 30 | 2024 | 394 | 4.530 |
Why?
|
| Multifactorial Inheritance | 10 | 2023 | 158 | 4.480 |
Why?
|
| Genome, Human | 37 | 2024 | 756 | 4.110 |
Why?
|
| Gene Expression Regulation | 29 | 2023 | 1920 | 3.790 |
Why?
|
| Models, Genetic | 31 | 2023 | 926 | 3.630 |
Why?
|
| Selection, Genetic | 23 | 2023 | 502 | 3.530 |
Why?
|
| Genetic Variation | 36 | 2022 | 1351 | 3.460 |
Why?
|
| Genome-Wide Association Study | 32 | 2023 | 1615 | 3.160 |
Why?
|
| Polymorphism, Single Nucleotide | 46 | 2023 | 2354 | 2.230 |
Why?
|
| Chromatin | 16 | 2020 | 380 | 2.120 |
Why?
|
| Sequence Analysis, RNA | 11 | 2018 | 217 | 1.990 |
Why?
|
| Gene Frequency | 22 | 2023 | 676 | 1.980 |
Why?
|
| Alleles | 23 | 2023 | 1127 | 1.640 |
Why?
|
| Adaptation, Physiological | 7 | 2016 | 306 | 1.610 |
Why?
|
| Evolution, Molecular | 18 | 2022 | 813 | 1.600 |
Why?
|
| Haplotypes | 18 | 2023 | 642 | 1.500 |
Why?
|
| Software | 10 | 2017 | 654 | 1.480 |
Why?
|
| Gene Expression | 11 | 2023 | 1281 | 1.440 |
Why?
|
| Chromosome Mapping | 16 | 2018 | 1074 | 1.410 |
Why?
|
| DNA, Ancient | 3 | 2024 | 18 | 1.370 |
Why?
|
| Linkage Disequilibrium | 14 | 2021 | 473 | 1.360 |
Why?
|
| Mutation Rate | 3 | 2017 | 48 | 1.320 |
Why?
|
| Protein Biosynthesis | 4 | 2018 | 378 | 1.250 |
Why?
|
| Computational Biology | 7 | 2015 | 528 | 1.210 |
Why?
|
| Genes, Duplicate | 2 | 2017 | 19 | 1.200 |
Why?
|
| Humans | 134 | 2024 | 86526 | 1.190 |
Why?
|
| DNA | 12 | 2020 | 1293 | 1.150 |
Why?
|
| Sequence Analysis, DNA | 13 | 2023 | 853 | 1.140 |
Why?
|
| RNA, Messenger | 9 | 2018 | 1980 | 1.130 |
Why?
|
| Major Histocompatibility Complex | 2 | 2016 | 81 | 1.130 |
Why?
|
| Gene Expression Profiling | 12 | 2019 | 1384 | 1.090 |
Why?
|
| Polymorphism, Genetic | 11 | 2019 | 819 | 1.010 |
Why?
|
| Deoxyribonuclease I | 4 | 2012 | 28 | 0.990 |
Why?
|
| Transcriptome | 8 | 2021 | 580 | 0.980 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2018 | 371 | 0.970 |
Why?
|
| Ribosomes | 4 | 2023 | 111 | 0.960 |
Why?
|
| Biological Specimen Banks | 2 | 2023 | 64 | 0.960 |
Why?
|
| DNA Methylation | 10 | 2020 | 625 | 0.950 |
Why?
|
| Genome | 11 | 2023 | 372 | 0.950 |
Why?
|
| Genetic Markers | 11 | 2016 | 476 | 0.940 |
Why?
|
| Transcription Factors | 10 | 2015 | 1559 | 0.930 |
Why?
|
| Gene Dosage | 3 | 2016 | 207 | 0.930 |
Why?
|
| Alternative Splicing | 2 | 2017 | 201 | 0.920 |
Why?
|
| Pan troglodytes | 5 | 2018 | 197 | 0.910 |
Why?
|
| Cell Line | 17 | 2023 | 2468 | 0.880 |
Why?
|
| Histones | 8 | 2015 | 311 | 0.870 |
Why?
|
| Genetic Loci | 6 | 2021 | 250 | 0.840 |
Why?
|
| Biological Evolution | 8 | 2020 | 918 | 0.830 |
Why?
|
| Phenotype | 20 | 2023 | 2377 | 0.770 |
Why?
|
| Immune System Diseases | 2 | 2022 | 25 | 0.770 |
Why?
|
| Disease | 4 | 2017 | 90 | 0.770 |
Why?
|
| Microsatellite Repeats | 8 | 2023 | 144 | 0.770 |
Why?
|
| Uric Acid | 1 | 2021 | 139 | 0.760 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2021 | 114 | 0.750 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2023 | 148 | 0.740 |
Why?
|
| Transcription, Genetic | 7 | 2018 | 1135 | 0.710 |
Why?
|
| Genetic Drift | 4 | 2023 | 37 | 0.700 |
Why?
|
| Bayes Theorem | 8 | 2014 | 361 | 0.700 |
Why?
|
| Heredity | 1 | 2019 | 19 | 0.700 |
Why?
|
| Testosterone | 1 | 2021 | 271 | 0.700 |
Why?
|
| Single-Cell Analysis | 2 | 2017 | 134 | 0.690 |
Why?
|
| Human Genetics | 2 | 2023 | 6 | 0.690 |
Why?
|
| Adaptation, Biological | 4 | 2019 | 85 | 0.690 |
Why?
|
| Genotype | 21 | 2022 | 1850 | 0.670 |
Why?
|
| Lactase | 2 | 2016 | 5 | 0.660 |
Why?
|
| Probability | 4 | 2023 | 355 | 0.660 |
Why?
|
| HapMap Project | 5 | 2014 | 47 | 0.660 |
Why?
|
| Macaca mulatta | 2 | 2018 | 459 | 0.640 |
Why?
|
| Mammals | 4 | 2023 | 227 | 0.640 |
Why?
|
| Genetic Diseases, Inborn | 4 | 2017 | 101 | 0.640 |
Why?
|
| Gene Conversion | 1 | 2017 | 25 | 0.630 |
Why?
|
| Gene Editing | 3 | 2023 | 42 | 0.630 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2015 | 133 | 0.620 |
Why?
|
| Human Migration | 3 | 2024 | 25 | 0.620 |
Why?
|
| Animals | 39 | 2023 | 26567 | 0.600 |
Why?
|
| Oligodendroglia | 1 | 2017 | 123 | 0.590 |
Why?
|
| Phylogeny | 8 | 2022 | 1136 | 0.590 |
Why?
|
| Microglia | 1 | 2017 | 102 | 0.590 |
Why?
|
| Genetics | 1 | 2016 | 24 | 0.580 |
Why?
|
| Open Reading Frames | 2 | 2016 | 117 | 0.580 |
Why?
|
| Bibliometrics | 1 | 2016 | 36 | 0.580 |
Why?
|
| Algorithms | 12 | 2018 | 1830 | 0.570 |
Why?
|
| Exons | 4 | 2014 | 450 | 0.560 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2016 | 109 | 0.560 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 1195 | 0.550 |
Why?
|
| Periodicals as Topic | 2 | 2016 | 167 | 0.550 |
Why?
|
| Molecular Biology | 1 | 2016 | 89 | 0.540 |
Why?
|
| Databases, Genetic | 5 | 2021 | 260 | 0.540 |
Why?
|
| Gene Duplication | 1 | 2016 | 125 | 0.530 |
Why?
|
| Neanderthals | 2 | 2017 | 15 | 0.520 |
Why?
|
| Mutation | 12 | 2022 | 3960 | 0.520 |
Why?
|
| RNA Splicing | 1 | 2016 | 142 | 0.510 |
Why?
|
| Freezing | 1 | 2014 | 33 | 0.510 |
Why?
|
| B-Lymphocytes | 3 | 2019 | 724 | 0.510 |
Why?
|
| Case-Control Studies | 4 | 2005 | 1803 | 0.500 |
Why?
|
| Fossils | 3 | 2013 | 336 | 0.500 |
Why?
|
| Recombination, Genetic | 11 | 2009 | 439 | 0.500 |
Why?
|
| Pedigree | 6 | 2016 | 966 | 0.480 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 371 | 0.480 |
Why?
|
| Schizophrenia | 1 | 2017 | 464 | 0.480 |
Why?
|
| Geography | 7 | 2017 | 223 | 0.470 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 470 | 0.470 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 55 | 0.470 |
Why?
|
| Population Density | 2 | 2011 | 60 | 0.470 |
Why?
|
| Nucleosomes | 2 | 2014 | 54 | 0.470 |
Why?
|
| Genetic Linkage | 5 | 2003 | 623 | 0.460 |
Why?
|
| Binding Sites | 4 | 2014 | 1098 | 0.460 |
Why?
|
| Base Sequence | 9 | 2016 | 2330 | 0.460 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2020 | 69 | 0.440 |
Why?
|
| United Kingdom | 5 | 2021 | 164 | 0.440 |
Why?
|
| Genomics | 7 | 2018 | 714 | 0.440 |
Why?
|
| Sequence Analysis | 2 | 2012 | 26 | 0.430 |
Why?
|
| DNA Footprinting | 1 | 2012 | 18 | 0.430 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 2269 | 0.420 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2017 | 101 | 0.420 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 476 | 0.410 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1208 | 0.410 |
Why?
|
| Population Dynamics | 4 | 2024 | 130 | 0.380 |
Why?
|
| Computer Simulation | 8 | 2017 | 1078 | 0.380 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2018 | 456 | 0.370 |
Why?
|
| Gene Regulatory Networks | 4 | 2022 | 291 | 0.370 |
Why?
|
| Penetrance | 2 | 2007 | 44 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 5 | 2014 | 937 | 0.360 |
Why?
|
| Physical Chromosome Mapping | 2 | 2007 | 27 | 0.360 |
Why?
|
| Molecular Sequence Annotation | 3 | 2017 | 67 | 0.360 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 689 | 0.350 |
Why?
|
| Models, Theoretical | 4 | 2019 | 482 | 0.350 |
Why?
|
| Bias | 2 | 2007 | 127 | 0.350 |
Why?
|
| Skin Pigmentation | 3 | 2023 | 40 | 0.340 |
Why?
|
| Primates | 3 | 2016 | 151 | 0.330 |
Why?
|
| CRISPR-Cas Systems | 3 | 2023 | 70 | 0.320 |
Why?
|
| Environment | 3 | 2010 | 219 | 0.320 |
Why?
|
| Mutagenesis | 3 | 2023 | 199 | 0.320 |
Why?
|
| Likelihood Functions | 4 | 2015 | 251 | 0.310 |
Why?
|
| Introns | 3 | 2017 | 289 | 0.310 |
Why?
|
| Europe | 5 | 2024 | 309 | 0.310 |
Why?
|
| Fetus | 2 | 2017 | 226 | 0.310 |
Why?
|
| Pongo | 2 | 2017 | 6 | 0.310 |
Why?
|
| Response Elements | 2 | 2019 | 63 | 0.310 |
Why?
|
| Epidemiologic Research Design | 1 | 2007 | 22 | 0.300 |
Why?
|
| Proteins | 3 | 2021 | 777 | 0.300 |
Why?
|
| Lymphocytes | 4 | 2016 | 463 | 0.300 |
Why?
|
| Secretory Vesicles | 2 | 2018 | 43 | 0.300 |
Why?
|
| Tetrahymena thermophila | 2 | 2018 | 51 | 0.290 |
Why?
|
| Gene Flow | 2 | 2019 | 88 | 0.290 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2004 | 124 | 0.280 |
Why?
|
| Genetic Pleiotropy | 2 | 2022 | 24 | 0.270 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 275 | 0.260 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 3 | 2022 | 22 | 0.260 |
Why?
|
| Chromosomes, Human | 3 | 2015 | 66 | 0.260 |
Why?
|
| Sequence Deletion | 1 | 2005 | 205 | 0.260 |
Why?
|
| Data Collection | 1 | 2006 | 372 | 0.260 |
Why?
|
| France | 1 | 2024 | 47 | 0.240 |
Why?
|
| Markov Chains | 4 | 2010 | 125 | 0.240 |
Why?
|
| Autoimmune Diseases | 2 | 2023 | 241 | 0.240 |
Why?
|
| Transcription Initiation Site | 4 | 2014 | 45 | 0.240 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1458 | 0.240 |
Why?
|
| Melanosomes | 1 | 2023 | 1 | 0.240 |
Why?
|
| Kruppel-Like Factor 6 | 1 | 2023 | 5 | 0.240 |
Why?
|
| Melanins | 1 | 2023 | 23 | 0.230 |
Why?
|
| Emigration and Immigration | 2 | 2019 | 48 | 0.230 |
Why?
|
| Narcolepsy | 1 | 2023 | 9 | 0.230 |
Why?
|
| Y Chromosome | 2 | 2000 | 28 | 0.230 |
Why?
|
| SOX9 Transcription Factor | 1 | 2023 | 23 | 0.230 |
Why?
|
| Melanocytes | 1 | 2023 | 56 | 0.230 |
Why?
|
| Ribosomal Proteins | 1 | 2023 | 43 | 0.230 |
Why?
|
| Pierre Robin Syndrome | 1 | 2023 | 13 | 0.230 |
Why?
|
| Reproducibility of Results | 5 | 2015 | 2705 | 0.230 |
Why?
|
| Sex Factors | 3 | 2021 | 1054 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2023 | 102 | 0.220 |
Why?
|
| RNA, Double-Stranded | 1 | 2022 | 22 | 0.220 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 20 | 0.220 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2023 | 102 | 0.220 |
Why?
|
| Genes, Regulator | 1 | 2022 | 65 | 0.220 |
Why?
|
| Endosomes | 2 | 2023 | 75 | 0.210 |
Why?
|
| Influenza Vaccines | 1 | 2023 | 142 | 0.210 |
Why?
|
| RNA Editing | 1 | 2022 | 34 | 0.210 |
Why?
|
| Mice | 10 | 2023 | 11339 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 302 | 0.200 |
Why?
|
| Zea mays | 1 | 2001 | 23 | 0.200 |
Why?
|
| Hominidae | 2 | 2006 | 95 | 0.200 |
Why?
|
| Reproduction | 2 | 2001 | 195 | 0.200 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 171 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2021 | 1373 | 0.200 |
Why?
|
| Blood Proteins | 1 | 2021 | 144 | 0.200 |
Why?
|
| Inheritance Patterns | 1 | 2021 | 48 | 0.200 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 222 | 0.200 |
Why?
|
| HIV-1 | 1 | 2022 | 163 | 0.190 |
Why?
|
| Microarray Analysis | 2 | 2014 | 96 | 0.190 |
Why?
|
| Africa | 5 | 2017 | 98 | 0.190 |
Why?
|
| Terminator Regions, Genetic | 2 | 2012 | 14 | 0.190 |
Why?
|
| Plant Proteins | 1 | 2001 | 132 | 0.190 |
Why?
|
| Population Groups | 3 | 2010 | 41 | 0.190 |
Why?
|
| RNA Splice Sites | 2 | 2010 | 53 | 0.190 |
Why?
|
| RNA Stability | 2 | 2012 | 86 | 0.190 |
Why?
|
| Face | 1 | 2021 | 114 | 0.190 |
Why?
|
| Paternity | 1 | 2000 | 8 | 0.190 |
Why?
|
| Cryptococcus neoformans | 1 | 2020 | 9 | 0.190 |
Why?
|
| Influenza, Human | 1 | 2023 | 329 | 0.180 |
Why?
|
| HLA Antigens | 2 | 2021 | 232 | 0.180 |
Why?
|
| Heterozygote | 3 | 2015 | 365 | 0.180 |
Why?
|
| Natural Science Disciplines | 1 | 2019 | 3 | 0.180 |
Why?
|
| Bone Density | 1 | 2021 | 209 | 0.180 |
Why?
|
| Viral Proteins | 1 | 2001 | 300 | 0.180 |
Why?
|
| Male | 22 | 2022 | 40944 | 0.180 |
Why?
|
| Sex | 1 | 1999 | 6 | 0.180 |
Why?
|
| Prosencephalon | 1 | 2020 | 62 | 0.180 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 329 | 0.180 |
Why?
|
| DNA, Plant | 1 | 2019 | 44 | 0.170 |
Why?
|
| Public Opinion | 1 | 2019 | 43 | 0.170 |
Why?
|
| Epigenomics | 2 | 2020 | 100 | 0.170 |
Why?
|
| Neurogenesis | 1 | 2020 | 74 | 0.170 |
Why?
|
| Cell Lineage | 4 | 2020 | 273 | 0.170 |
Why?
|
| Societies, Scientific | 1 | 2019 | 44 | 0.170 |
Why?
|
| Exome | 2 | 2016 | 127 | 0.170 |
Why?
|
| Research Personnel | 1 | 2019 | 67 | 0.170 |
Why?
|
| Protein Binding | 5 | 2015 | 1456 | 0.170 |
Why?
|
| Body Height | 1 | 2019 | 99 | 0.170 |
Why?
|
| Genetic Complementation Test | 2 | 2008 | 97 | 0.170 |
Why?
|
| Methyltransferases | 1 | 2020 | 182 | 0.170 |
Why?
|
| Acclimatization | 4 | 2017 | 76 | 0.170 |
Why?
|
| Congresses as Topic | 1 | 2019 | 116 | 0.170 |
Why?
|
| Female | 18 | 2022 | 44489 | 0.160 |
Why?
|
| Monte Carlo Method | 3 | 2010 | 185 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 3 | 2015 | 114 | 0.160 |
Why?
|
| Cardiotoxicity | 1 | 2018 | 9 | 0.160 |
Why?
|
| Organ Specificity | 2 | 2016 | 258 | 0.160 |
Why?
|
| Anthracyclines | 1 | 2018 | 37 | 0.160 |
Why?
|
| Base Composition | 1 | 2017 | 35 | 0.160 |
Why?
|
| History, Ancient | 4 | 2023 | 74 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2818 | 0.160 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 267 | 0.160 |
Why?
|
| Gorilla gorilla | 1 | 2017 | 40 | 0.160 |
Why?
|
| Pseudogenes | 1 | 1997 | 35 | 0.160 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 154 | 0.160 |
Why?
|
| Statistical Distributions | 2 | 2012 | 9 | 0.150 |
Why?
|
| Macaca | 1 | 2017 | 87 | 0.150 |
Why?
|
| Protozoan Proteins | 1 | 2018 | 73 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2015 | 45 | 0.150 |
Why?
|
| Transplantation | 1 | 2017 | 39 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2016 | 175 | 0.150 |
Why?
|
| Minisatellite Repeats | 1 | 1996 | 24 | 0.150 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 68 | 0.150 |
Why?
|
| Hair Color | 1 | 2016 | 8 | 0.150 |
Why?
|
| Eye Color | 1 | 2016 | 8 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 173 | 0.150 |
Why?
|
| CD4 Antigens | 1 | 1996 | 83 | 0.150 |
Why?
|
| Inflammation | 1 | 2022 | 919 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2016 | 312 | 0.150 |
Why?
|
| Altitude | 2 | 2014 | 40 | 0.150 |
Why?
|
| Animals, Outbred Strains | 1 | 2016 | 15 | 0.140 |
Why?
|
| Genes, Insect | 1 | 1997 | 183 | 0.140 |
Why?
|
| Dogs | 3 | 2012 | 685 | 0.140 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2016 | 17 | 0.140 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2016 | 11 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 135 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 129 | 0.140 |
Why?
|
| Neoplasms | 2 | 2023 | 2895 | 0.140 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 2426 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 292 | 0.140 |
Why?
|
| Human Genome Project | 1 | 2015 | 19 | 0.140 |
Why?
|
| Temperature | 2 | 2014 | 396 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 339 | 0.130 |
Why?
|
| Communication | 1 | 2019 | 440 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 266 | 0.130 |
Why?
|
| Hematopoiesis | 1 | 2016 | 163 | 0.130 |
Why?
|
| Species Specificity | 5 | 2014 | 678 | 0.130 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 434 | 0.130 |
Why?
|
| Aging | 2 | 2018 | 690 | 0.130 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 37 | 0.130 |
Why?
|
| Transformation, Genetic | 1 | 2014 | 40 | 0.130 |
Why?
|
| Mitochondria | 1 | 1998 | 535 | 0.130 |
Why?
|
| Biomarkers | 1 | 2021 | 1716 | 0.120 |
Why?
|
| Cryopreservation | 1 | 2014 | 68 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2014 | 3 | 0.120 |
Why?
|
| High Mobility Group Proteins | 1 | 2014 | 26 | 0.120 |
Why?
|
| Drosophila melanogaster | 2 | 2003 | 599 | 0.120 |
Why?
|
| Artifacts | 1 | 2015 | 244 | 0.120 |
Why?
|
| Cells | 1 | 2013 | 32 | 0.120 |
Why?
|
| HIV Infections | 1 | 2022 | 772 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2016 | 373 | 0.110 |
Why?
|
| Micrococcal Nuclease | 1 | 2012 | 8 | 0.110 |
Why?
|
| Brain | 2 | 2021 | 2214 | 0.110 |
Why?
|
| Wolves | 1 | 2012 | 10 | 0.110 |
Why?
|
| Encyclopedias as Topic | 1 | 2012 | 4 | 0.110 |
Why?
|
| Population | 1 | 2012 | 35 | 0.110 |
Why?
|
| Cluster Analysis | 5 | 2014 | 369 | 0.110 |
Why?
|
| Breeding | 1 | 2012 | 39 | 0.110 |
Why?
|
| Mice, Inbred DBA | 2 | 2023 | 148 | 0.110 |
Why?
|
| RNA | 1 | 2017 | 560 | 0.110 |
Why?
|
| Nuclear Lamina | 1 | 2012 | 7 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2016 | 2765 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 165 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2012 | 179 | 0.110 |
Why?
|
| Amino Acids | 2 | 2023 | 252 | 0.110 |
Why?
|
| Mediterranean Region | 2 | 2023 | 4 | 0.110 |
Why?
|
| Darkness | 1 | 2011 | 49 | 0.100 |
Why?
|
| Lemur | 1 | 2011 | 12 | 0.100 |
Why?
|
| Mitosis | 1 | 2012 | 153 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2012 | 172 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 3 | 2003 | 297 | 0.100 |
Why?
|
| Adult | 8 | 2022 | 25627 | 0.100 |
Why?
|
| Computers | 1 | 2011 | 112 | 0.100 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 2006 | 19 | 0.100 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2010 | 5 | 0.100 |
Why?
|
| DNA Cleavage | 1 | 2010 | 7 | 0.100 |
Why?
|
| Climate | 1 | 2011 | 50 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 878 | 0.100 |
Why?
|
| Gene Pool | 2 | 2007 | 6 | 0.100 |
Why?
|
| Consensus Sequence | 1 | 2010 | 64 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 757 | 0.090 |
Why?
|
| Principal Component Analysis | 2 | 2023 | 155 | 0.090 |
Why?
|
| Diet | 2 | 2010 | 442 | 0.090 |
Why?
|
| Nigeria | 1 | 2010 | 152 | 0.090 |
Why?
|
| Research Design | 3 | 2007 | 594 | 0.090 |
Why?
|
| Neuregulins | 1 | 2009 | 5 | 0.090 |
Why?
|
| Receptor, ErbB-4 | 1 | 2009 | 5 | 0.090 |
Why?
|
| DNA, Complementary | 1 | 2010 | 393 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 488 | 0.090 |
Why?
|
| Crossing Over, Genetic | 1 | 2008 | 33 | 0.080 |
Why?
|
| Middle Aged | 5 | 2021 | 25013 | 0.080 |
Why?
|
| Internet | 1 | 2010 | 312 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 48 | 0.080 |
Why?
|
| Hypoxia | 1 | 2012 | 641 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 1988 | 0.080 |
Why?
|
| Sequence Tagged Sites | 1 | 2006 | 11 | 0.070 |
Why?
|
| Mental Disorders | 2 | 2021 | 371 | 0.070 |
Why?
|
| Venereal Tumors, Veterinary | 1 | 2006 | 1 | 0.070 |
Why?
|
| Lactose | 1 | 2006 | 27 | 0.070 |
Why?
|
| DNA, Mitochondrial | 3 | 2006 | 183 | 0.070 |
Why?
|
| Canidae | 1 | 2006 | 5 | 0.070 |
Why?
|
| Family | 2 | 2005 | 311 | 0.070 |
Why?
|
| Sample Size | 1 | 2007 | 130 | 0.070 |
Why?
|
| Dog Diseases | 1 | 2006 | 35 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 3030 | 0.070 |
Why?
|
| Helicobacter pylori | 2 | 2003 | 35 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 485 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2023 | 3092 | 0.070 |
Why?
|
| Young Adult | 2 | 2014 | 5971 | 0.070 |
Why?
|
| International Cooperation | 1 | 2005 | 127 | 0.070 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 307 | 0.070 |
Why?
|
| Multigene Family | 1 | 2005 | 202 | 0.060 |
Why?
|
| Survivors | 1 | 2006 | 226 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2004 | 57 | 0.060 |
Why?
|
| Nuclear Family | 2 | 2003 | 92 | 0.060 |
Why?
|
| Gain of Function Mutation | 1 | 2023 | 13 | 0.060 |
Why?
|
| Calpain | 1 | 2004 | 111 | 0.060 |
Why?
|
| Middle East | 2 | 2019 | 17 | 0.060 |
Why?
|
| Burial | 1 | 2023 | 2 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2005 | 185 | 0.060 |
Why?
|
| Anthropology | 1 | 2023 | 8 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2004 | 193 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 112 | 0.060 |
Why?
|
| Archaeology | 1 | 2023 | 14 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 623 | 0.060 |
Why?
|
| Loss of Function Mutation | 1 | 2023 | 42 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2003 | 36 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 64 | 0.060 |
Why?
|
| Ketones | 1 | 2022 | 13 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2003 | 34 | 0.060 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2022 | 10 | 0.060 |
Why?
|
| Inosine | 1 | 2022 | 19 | 0.060 |
Why?
|
| Vertebrates | 1 | 2023 | 90 | 0.050 |
Why?
|
| Alu Elements | 1 | 2022 | 15 | 0.050 |
Why?
|
| Genetics, Medical | 1 | 2002 | 52 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2004 | 751 | 0.050 |
Why?
|
| Netherlands | 1 | 2022 | 19 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2006 | 351 | 0.050 |
Why?
|
| Clone Cells | 2 | 2016 | 213 | 0.050 |
Why?
|
| RNA Interference | 2 | 2014 | 369 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2022 | 66 | 0.050 |
Why?
|
| Autoimmunity | 1 | 2023 | 160 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 132 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2022 | 74 | 0.050 |
Why?
|
| Americas | 3 | 2009 | 19 | 0.050 |
Why?
|
| Viral Load | 1 | 2022 | 148 | 0.050 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 62 | 0.050 |
Why?
|
| Carnivora | 1 | 2001 | 10 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 44 | 0.050 |
Why?
|
| Virulence | 1 | 2022 | 271 | 0.050 |
Why?
|
| Jews | 1 | 2001 | 42 | 0.050 |
Why?
|
| Genes, Plant | 1 | 2001 | 99 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 364 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2023 | 728 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 43 | 0.050 |
Why?
|
| Cats | 1 | 2001 | 303 | 0.050 |
Why?
|
| Behavior | 1 | 2021 | 85 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 2021 | 100 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2021 | 95 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2023 | 666 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2021 | 145 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 246 | 0.050 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 18 | 0.050 |
Why?
|
| DNA Modification Methylases | 1 | 2020 | 25 | 0.050 |
Why?
|
| Rome | 1 | 2019 | 1 | 0.050 |
Why?
|
| Africa, Northern | 1 | 2019 | 5 | 0.050 |
Why?
|
| Ploidies | 1 | 2000 | 40 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 147 | 0.050 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 31 | 0.050 |
Why?
|
| Allelic Imbalance | 1 | 2019 | 20 | 0.050 |
Why?
|
| Adenosine | 1 | 2022 | 225 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 776 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 55 | 0.040 |
Why?
|
| Adipocytes | 1 | 2021 | 155 | 0.040 |
Why?
|
| Anti-HIV Agents | 1 | 2022 | 149 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 61 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 34 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2019 | 127 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2019 | 89 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 2020 | 169 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 348 | 0.040 |
Why?
|
| Biostatistics | 1 | 2019 | 20 | 0.040 |
Why?
|
| Models, Statistical | 2 | 2017 | 574 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2022 | 407 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2019 | 249 | 0.040 |
Why?
|
| Drosophila | 2 | 2014 | 498 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 151 | 0.040 |
Why?
|
| Antibody Diversity | 1 | 1998 | 25 | 0.040 |
Why?
|
| Paleontology | 1 | 2019 | 81 | 0.040 |
Why?
|
| Yeasts | 1 | 2018 | 49 | 0.040 |
Why?
|
| Epistasis, Genetic | 1 | 2018 | 86 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 351 | 0.040 |
Why?
|
| Africa South of the Sahara | 2 | 2011 | 21 | 0.040 |
Why?
|
| Quality of Life | 1 | 2006 | 1583 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 999 | 0.040 |
Why?
|
| Ethiopia | 2 | 2012 | 37 | 0.040 |
Why?
|
| Models, Biological | 2 | 2010 | 1749 | 0.040 |
Why?
|
| Risk | 1 | 1999 | 674 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 567 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2018 | 295 | 0.040 |
Why?
|
| Insect Proteins | 1 | 1997 | 88 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 396 | 0.040 |
Why?
|
| Transplants | 1 | 2017 | 40 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2018 | 439 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2004 | 2261 | 0.040 |
Why?
|
| Myelopoiesis | 1 | 2016 | 10 | 0.040 |
Why?
|
| Cognition | 1 | 2021 | 570 | 0.040 |
Why?
|
| Cytosol | 1 | 2016 | 189 | 0.040 |
Why?
|
| Exocytosis | 1 | 2016 | 108 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 30 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 350 | 0.030 |
Why?
|
| Twins | 1 | 2015 | 65 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2017 | 435 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 812 | 0.030 |
Why?
|
| 3' Flanking Region | 1 | 2014 | 5 | 0.030 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 16 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1849 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 1041 | 0.030 |
Why?
|
| Genetic Load | 1 | 2014 | 4 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2017 | 463 | 0.030 |
Why?
|
| Tibet | 1 | 2014 | 19 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 5413 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 827 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 294 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 18398 | 0.030 |
Why?
|
| Altitude Sickness | 1 | 2012 | 10 | 0.030 |
Why?
|
| Langerhans Cells | 1 | 1992 | 13 | 0.030 |
Why?
|
| Asia | 2 | 2003 | 94 | 0.030 |
Why?
|
| United States | 1 | 2005 | 6662 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 729 | 0.030 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2012 | 43 | 0.030 |
Why?
|
| Isoantigens | 1 | 1992 | 66 | 0.030 |
Why?
|
| Nuclear Envelope | 1 | 2012 | 36 | 0.030 |
Why?
|
| CpG Islands | 1 | 2012 | 151 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 63 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 105 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2012 | 131 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2012 | 79 | 0.030 |
Why?
|
| Madagascar | 1 | 2011 | 27 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 547 | 0.030 |
Why?
|
| Endangered Species | 1 | 2011 | 23 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 63 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 130 | 0.030 |
Why?
|
| Nucleotides | 1 | 2011 | 95 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2017 | 1065 | 0.030 |
Why?
|
| Language | 2 | 2003 | 151 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1197 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 193 | 0.020 |
Why?
|
| Homozygote | 1 | 2010 | 200 | 0.020 |
Why?
|
| Ecology | 1 | 2010 | 74 | 0.020 |
Why?
|
| Genealogy and Heraldry | 1 | 2009 | 13 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2015 | 730 | 0.020 |
Why?
|
| Skin | 1 | 1992 | 554 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3350 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 86 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 177 | 0.020 |
Why?
|
| Paternal Age | 1 | 2008 | 5 | 0.020 |
Why?
|
| Antiporters | 1 | 2008 | 18 | 0.020 |
Why?
|
| Maternal Age | 1 | 2008 | 44 | 0.020 |
Why?
|
| Salivary Proteins and Peptides | 1 | 2007 | 5 | 0.020 |
Why?
|
| Amylases | 1 | 2007 | 13 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 534 | 0.020 |
Why?
|
| Meiosis | 1 | 2008 | 80 | 0.020 |
Why?
|
| Lactose Tolerance Test | 1 | 2006 | 2 | 0.020 |
Why?
|
| Genomic Library | 1 | 2006 | 33 | 0.020 |
Why?
|
| India | 1 | 2007 | 120 | 0.020 |
Why?
|
| Milk | 1 | 2006 | 53 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2006 | 123 | 0.020 |
Why?
|
| Time | 1 | 2006 | 77 | 0.020 |
Why?
|
| Saliva | 1 | 2007 | 122 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 2006 | 35 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2006 | 55 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 1229 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 141 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2006 | 79 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 1 | 2006 | 92 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2008 | 271 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2008 | 319 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 204 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2006 | 265 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2005 | 100 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 504 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2006 | 579 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 927 | 0.020 |
Why?
|
| Health Status | 1 | 2006 | 360 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2003 | 53 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2006 | 337 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2003 | 87 | 0.010 |
Why?
|
| Authorship | 1 | 2003 | 24 | 0.010 |
Why?
|
| Polynesia | 1 | 2003 | 3 | 0.010 |
Why?
|
| Social Problems | 1 | 2003 | 10 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 307 | 0.010 |
Why?
|
| Pacific Islands | 1 | 2002 | 2 | 0.010 |
Why?
|
| Chromosomes | 1 | 2003 | 96 | 0.010 |
Why?
|
| Indians, North American | 1 | 2003 | 48 | 0.010 |
Why?
|
| Agriculture | 1 | 2003 | 38 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2003 | 198 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2006 | 3610 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1981 | 47 | 0.010 |
Why?
|
| Child | 3 | 2006 | 6921 | 0.010 |
Why?
|
| Tumor Virus Infections | 1 | 1981 | 81 | 0.010 |
Why?
|
| Yemen | 1 | 2001 | 1 | 0.010 |
Why?
|
| Libya | 1 | 2001 | 3 | 0.010 |
Why?
|
| Iraq | 1 | 2001 | 2 | 0.010 |
Why?
|
| Scotland | 1 | 2001 | 6 | 0.010 |
Why?
|
| Poland | 1 | 2001 | 17 | 0.010 |
Why?
|
| Morocco | 1 | 2001 | 16 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1981 | 107 | 0.010 |
Why?
|
| Israel | 1 | 2001 | 55 | 0.010 |
Why?
|
| Arabs | 1 | 2001 | 17 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 1619 | 0.010 |
Why?
|
| Animals, Wild | 1 | 2001 | 40 | 0.010 |
Why?
|
| Hair | 1 | 2001 | 56 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 912 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1981 | 293 | 0.010 |
Why?
|
| Hybridization, Genetic | 1 | 2001 | 104 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 3040 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 596 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 3636 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2006 | 2499 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 863 | 0.010 |
Why?
|
| Adolescent | 2 | 2006 | 8976 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1992 | 458 | 0.010 |
Why?
|
| Photomicrography | 1 | 1981 | 7 | 0.000 |
Why?
|
| Blood Cell Count | 1 | 1981 | 79 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1981 | 80 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1981 | 154 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1981 | 456 | 0.000 |
Why?
|